The administration of chronic lymphocytic leukemia (CLL) has evolved dramatically within
The administration of chronic lymphocytic leukemia (CLL) has evolved dramatically within the last decade. v 72% 0.001)F v ClbRai3964350CR: 20% v 4% ( 0.001) 0.001) 0.001)FCR v FCHallek4061817CR: 44% v 22% ( 0.0001) 0.0001) 0.001)= 0.01)SLOW-GO patientsBendamustine vs ClbKnauf6563319CR: 31% v 2% 0.0001) 0.0001)F v ClbEichhorst6370ORR: 72% v 51% (= 0.003)= 0.011)= 0.7)Relapse treatmentGO-GO individuals?FCR … [Read more…]